price
GM
NYSE · GMAB
Genmab A/S
Healthcare · Biotechnology
$33.23
Down-$0.87 (-2.55%)
Updated Aug 30, 2026, 11:48 AM
SID Score
7.5/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 19.89B
- P/E ratio
- 14.56
- Dividend yield
- 0.00%
- 52-week range
- $23.62 – $35.43
- Volume
- 1.52M
- Avg. volume
- 2.09M
Price performance
GMAB price history
1M range · 20 trading sessions · Daily adjusted prices
GMAB closed at $33.23 after 20 trading sessions, up 15.86% for the selected period.
- Last close
- $33.23
- Period change
- +15.86%
- Period low
- $28.68
- Period high
- $34.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $33.78 | $33.9295 | $33.115 | $33.23 | 1.52M |
| Aug 27, 2026 | $33.91 | $34.165 | $33.67 | $34.10 | 1.87M |
| Aug 26, 2026 | $33.78 | $33.90 | $33.36 | $33.75 | 3.09M |
| Aug 25, 2026 | $33.81 | $34.4699 | $33.72 | $34.36 | 2.03M |
| Aug 24, 2026 | $32.82 | $33.32 | $32.74 | $33.02 | 3.25M |
| Aug 21, 2026 | $33.36 | $33.98 | $33.28 | $33.45 | 2.54M |
| Aug 20, 2026 | $33.60 | $33.77 | $33.20 | $33.41 | 6.35M |
| Aug 19, 2026 | $33.41 | $34.185 | $33.255 | $34.11 | 3.23M |
| Aug 18, 2026 | $32.86 | $33.11 | $32.66 | $32.96 | 2.71M |
| Aug 17, 2026 | $32.31 | $32.935 | $32.28 | $32.84 | 3.43M |
| Aug 14, 2026 | $31.31 | $31.98 | $31.14 | $31.94 | 3.43M |
| Aug 13, 2026 | $31.50 | $31.55 | $30.98 | $31.34 | 4.09M |
| Aug 12, 2026 | $30.69 | $31.61 | $30.69 | $31.42 | 3.52M |
| Aug 11, 2026 | $30.91 | $30.98 | $30.52 | $30.85 | 1.59M |
| Aug 10, 2026 | $30.63 | $31.01 | $30.55 | $30.87 | 2.8M |
| Aug 7, 2026 | $31.44 | $31.79 | $30.915 | $31.25 | 3.51M |
| Aug 6, 2026 | $29.50 | $29.86 | $28.47 | $29.83 | 5.23M |
| Aug 5, 2026 | $29.46 | $29.77 | $29.21 | $29.26 | 1.4M |
| Aug 4, 2026 | $29.24 | $29.32 | $28.94 | $29.02 | 1.32M |
| Aug 3, 2026 | $28.645 | $28.72 | $28.09 | $28.68 | 1.74M |
Latest GMAB news
The latest Smart Investors Daily articles mentioning GMAB.
Stock researchCompany · Financials
Loading stock research…